DAXX and myelodysplastic syndrome: Attieh et al. evaluated bone marrow (BM) aspiration samples from 77 patients with myelodysplastic neoplasms (MDS) and identified that DAXX mRNA expression in MDS CD34+ cells, assessed by real-time PCR, was significantly upregulated compared to healthy controls.